Trial Profile
Long-term Study of DSP-8153 in patients with essential hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 May 2016
Price :
$35
*
At a glance
- Drugs Amlodipine/irbesartan (Primary)
- Indications Essential hypertension
- Focus Adverse reactions; Registrational
- Sponsors Sumitomo Dainippon Pharma
- 21 May 2016 New trial record